The insulin signal pathway of the brain in patients with AD was impaired and the activity of GSK-3β was significantly increased; the activation of GSK-3β in the hippocampus led to phosphorylation of Tau proteins in the T2DM rodent, which further affected memory impairment (Dey et al., 2017). This evidence concerns the gene GSK3B and Alzheimer disease.